Logo for KALA BIO Inc

KALA BIO Investor Relations Material

Latest events

Logo for KALA BIO Inc

Q2 2022

KALA BIO
Logo for KALA BIO

Q3 2024

12 Nov, 2024
Logo for KALA BIO

Q2 2024

6 Aug, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies

Latest reports from KALA BIO Inc

Access all reports
KALA BIO Inc. (formerly Kala Pharmaceuticals Inc.) is a biopharmaceutical company focused on developing and commercializing innovative treatments for ocular diseases. The company leverages its proprietary AMPPLIFY drug delivery technology, which enhances the penetration of therapeutic agents into target tissues. KALA BIO’s product portfolio includes treatments for conditions such as dry eye disease, ocular inflammation, and other front-of-the-eye disorders. The company is headquartered in Arlington, Massachusetts, and its shares are listed on the NASDAQ.